iMed.ULisboa researchers contribute to the diagnosis of COVID-19
The iMed.ULisboa will contribute to the diagnosis of COVID-19 from March 27, 2020. The Research Institute for Medicines will use technical and scientific resources to the screening and identification of SARS-Cov-2 at the community level. This competence was recognized by the National Institute of Health Doutor Ricardo Jorge (INSA).
More information: www.ff.ul.pt